|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,466.40 INR | -0.54% |
|
+3.63% | -2.97% |
| 07-28 | Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus | CI |
| 07-24 | Jefferies Adjusts Cipla's Price Target to INR1,170 From INR1,120, Keeps at Underperform | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 12.43B | |||||
| 49.85B | |||||
| 36.89B | |||||
| 11.69B | |||||
| 9.04B | |||||
| 7.15B |
- Stock Market
- Stocks
- CIPLA Stock
- Charts Cipla Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
